Document is current
Any future updates will be listed below
-
Authors
Schreiber, Julian A. https://orcid.org/0000-0002-3847-7539
Möller, Melina
Zaydman, Mark
Zhao, Lu
Beller, Zachary
Becker, Sebastian
Ritter, Nadine
Hou, Panpan
Shi, Jingyi
Silva, Jon
Wrobel, Eva
Strutz-Seebohm, Nathalie
Decher, Niels https://orcid.org/0000-0002-9433-687X
Schmitt, Nicole https://orcid.org/0000-0001-9482-9749
Meuth, Sven G.
Düfer, Martina
Wünsch, Bernhard https://orcid.org/0000-0002-9030-8417
Cui, Jianmin https://orcid.org/0000-0002-9198-6332
Seebohm, Guiscard https://orcid.org/0000-0001-9303-5373
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (Graduate Cschool Chembion, DFG-Se 1077-13/1-3)
- License Information
-
More Information
Article History
Received: 4 September 2020
Accepted: 22 February 2022
First Online: 1 April 2022
Competing interests
: The authors declare the following competing interests: J.i.S. and J.C. are cofounders of a startup company VivoCor LLC, which is targeting IKs for the treatment of cardiac arrhythmia. Other authors declare they have no competing interests.
